Serum apoptosis markers in acute liver failure: a pilot study

Area of Science:

• Hepatology
• Biomarker Discovery
• Cellular Apoptosis

Background:

• Acute liver failure (ALF) is a critical condition with significant mortality.
• Identifying reliable biomarkers for ALF diagnosis and prognosis is crucial.
• Circulating apoptotic markers may offer insights into ALF pathogenesis and outcomes.

Purpose of the Study:

• To investigate alterations in circulating apoptotic markers in ALF.
• To determine if these markers differ based on ALF etiology.
• To assess the predictive value of apoptotic markers for clinical outcomes in ALF.

Main Methods:

• Serum levels of soluble Fas (sFas), TNF-alpha, HGF, and IL-6 were measured in 67 ALF patients and controls.
• Serum M-30 antigen, a marker of caspase cleavage, was quantified.
• M-30 immunoreactivity was assessed in liver tissue biopsies from ALF patients and controls.

Main Results:

• TNF-alpha, HGF, IL-6, and M-30 antigen levels were significantly elevated (≥10-fold) in ALF patients compared to controls.
• sFas and HGF levels varied by ALF etiology, with higher values in drug-induced and acetaminophen-related ALF.
• Elevated M-30 antigen levels were associated with increased likelihood of transplantation or mortality (P = .026).

Conclusions:

• Key apoptotic markers (TNF-alpha, HGF, IL-6, M-30 antigen) are significantly elevated in ALF.
• sFas and HGF may aid in diagnosing drug-induced or acetaminophen-related ALF.
• M-30 antigen levels serve as a significant predictor of poor clinical outcomes in ALF.